Growth Metrics

Kiora Pharmaceuticals (KPRX) Cash from Investing Activities (2016 - 2025)

Kiora Pharmaceuticals' Cash from Investing Activities history spans 8 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 1008.21% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $14.4 million, up 163.66%, while the annual FY2025 figure was $14.4 million, 163.66% up from the prior year.
  • Cash from Investing Activities reached $5.3 million in Q4 2025 per KPRX's latest filing, down from $5.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $5.7 million in Q3 2025 to a low of -$21.2 million in Q2 2024.
  • Average Cash from Investing Activities over 5 years is -$699415.5, with a median of $314.5 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: crashed 332839.67% in 2024, then surged 1008.21% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$93155.0 in 2021, then skyrocketed by 106.84% to $6375.0 in 2022, then tumbled by 200.0% to -$6375.0 in 2023, then soared by 7671.5% to $482683.0 in 2024, then soared by 1008.21% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Cash from Investing Activities are $5.3 million (Q4 2025), $5.7 million (Q3 2025), and $664172.0 (Q2 2025).